secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001558370-25-006594
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q3 revenue $316.2M (+6% organic), adj EPS $0.56, declares $0.08 dividend and $500M buyback
--------------------------------------------------------------------------------

- Q3 organic revenue +6% to $316.2M; GAAP EPS $0.14 vs $0.31 YoY; adjusted EPS $0.56 vs $0.48 YoY.
- Protein Sciences segment organic growth 7% (reported 6%) on improved pharma demand and commercial execution.
- Adjusted operating margin improved to 34.9% from 33.0% YoY; reported margin 12.2% (incl. charges).
- Declared quarterly dividend $0.08/share, payable May 30, 2025 to holders of record May 19, 2025.
- Board approved new $500M share repurchase program, effective May 8, 2025, replacing prior program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837025006594/0001558370-25-006594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837025006594/tech-20250507x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-006594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer